FDA Archives - Page 216 of 220

1 minute read

Abbott’s Deep Brain Stimulation Receives FDA’s Breakthrough Device Tag To Manage Depression

July 12, 10:20 AM

The FDA has granted Breakthrough Device Designation to Abbott Laboratories (NYSE:ABT) deep brain stimulation (DBS) system in treatment-resistant depression (TRD), a form…

ABT

1 minute read

FDA
News

‘Delaware Health Officials Report First Probable Case Of Monkeypox’ -CBS Philly

By Benzinga Newsdesk

July 12, 10:17 AM

https://philadelphia.cbslocal.com/2022/07/12/delaware-first-monkeypox-case/

AEMD

3 minute read

Abbott Receives FDA’s Breakthrough Device Designation To Explore Use Of Deep Brain Stimulation To Manage Severe Depression

By Bill Haddad

July 12, 9:09 AM

Breakthrough Device Designations are given by the U.S. FDA to expedite the review of technologies that can improve the lives of people with life-threatening or debilitating conditions Each year, 2.8 million Americans

ABT

1 minute read

FDA
News

UPDATE: Greenwich LifeSciences Says FDA Is Currently Reviewing Manufacturing Data, Has Sent Co. Follow Up Questions To Which Co. Has Responded; Co. Says 3rd Lot Was Manufactured In Commercial Facility On Automated Filling Line

By Michael Horton

July 11, 5:11 PM

-Reuters

GLSI

2 minute read

FDA
News

Neuronetics Announces TMS Coverage Policies To Expand Patient Access To NeuroStar TMS Therapy For Mental Health

By Benzinga Newsdesk

July 11, 4:47 PM

Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in

STIM

5 minute read

FDA
News

GSK Prepares Us For 2022-23 Flu Season With Over 50M Influenza Vaccine Doses

By Benzinga Newsdesk

July 11, 3:27 PM

GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses GSK begins shipping FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT GSK plc (NYSE:GSK) today announced it has started shipping doses of

GSK

1 minute read

Iterum Therapeutics Shares Are Surging – Read Why

By Vandana Singh

July 11, 2:31 PM

Iterum Therapeutics plc (NASDAQ:ITRM) has agreed with the FDA under the special protocol assessment (SPA) process on the design, endpoints, and…

ITRM

1 minute read

Aethlon Medical Secures FDA Clearance For Amendment In Initial-Stage COVID-19 Study

By Ragothaman Srinivasan

July 11, 11:41 AM

The U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of the ongoing clinical trial investigating Aethlon Medical’s (NASDAQ: AEMD) lead therapy Aethlon Hemopurifier for patients with severe COVID-19.

AEMD